期刊文献+

药品使用评估的介绍及其借鉴意义 被引量:2

药品使用评估的介绍及其借鉴意义
原文传递
导出
摘要 利用文献材料介绍药品使用评估(drug utilization review,DUR)的主要内容。在过去的几十年中,DUR改变了美国的药品使用模式,使之演化为一个控制费用并提升医疗质量的有效的工具。DUR对我国药品监管部门的工作,特别是医疗保险制度的实施和药品安全监督工作具有借鉴意义。 Drug utilization review (DUR) has played an important role in monitoring the patterns of medication use over the past four decades and has been evolving into a more powerful tool for cost containment and quality of care enhancement. Now we introduce the general concepts and procedures of U.S. drug utilization review. We reviewed the relevant literature and personal experience about DUR programs in U.S., and described several major concepts, procedures, and DUR applications. We suggested that DUR could be a useful and effective tool for our Chinese pharmaceutical administration, especially in the areas of medical insurance system, pharmacy practice, drug safety and post-marketing surveillance.
出处 《中国药物经济学》 2011年第1期72-77,共6页 China Journal of Pharmaceutical Economics
  • 相关文献

参考文献23

  • 1Government Printing Office (1969).Final Report,Task Force on Prescription Drugs.Washington:Government Printing Office,48.
  • 2Federal Register.Department of Health and Human Services.Rules and Regulations.Federal Register,1992,57(212):49397-49412.
  • 3Fulda TR,Collins T,Kuhle J,Devereanx DS,Zuckerman IH.Medicaid drug utilization review annual reports for federal fiscal year 1999:looking back to move forward.J Am Pharm Assoc,2004,44(1):69-74.
  • 4Sandusky M.Michigan drug utilization review and OBRA' 90.Mcih Med,1993,92(4):38-39.
  • 5Zuckerman IH,Mulhearn DM,Metge CJ.Inter-and Intrarater reliability of retrospective drug utilization reviewers.J Am Pharm Assoc,199939(1):45-49.
  • 6Guo JJ,Gibson JT,Hancock GR,Barker KN,May T.Economic evaluation of retrospective drug utilization review on the Medicaid pharmacy dispensing behavior.J Res Pharmaceutical Economics,1997,8(2):25-41.
  • 7Guo JJ,Gibson JT,Hancock GR,and Barker KN.Retrospective drug utilization review and the behavior of Medicaid prescribers:an empirical analysis.Clinical Therapeutics,1995,17(6):1174-1187.
  • 8Campbell,W H,& Johnson,R E.A Procedural and Conceptual Analysis of Drug Use Review,Drugs in Health Care,1975,(2):214.
  • 9Woolfrey S,Gammack NS,Dewar MS,Brown PJ.Fluoxetinewarfarin interaction.BMJA993,307(6898):241.
  • 10Nesto RW,Bell D,Bonow RO,et al.Thiazolidinedione use,fluid retention,and congestive heart failure.A consensus statement from the American Heart Association (AHA) and the American Diabetes Association (ADA).Circulation,2003,108:2941-2948.

同被引文献13

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部